These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28942878)
1. Incidence of colorectal cancer in new users and non-users of low-dose aspirin without existing cardiovascular disease: A cohort study using The Health Improvement Network. Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA Int J Cardiol; 2017 Dec; 248():376-381. PubMed ID: 28942878 [TBL] [Abstract][Full Text] [Related]
2. New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice. García Rodríguez LA; Soriano-Gabarró M; Bromley S; Lanas A; Cea Soriano L BMC Cancer; 2017 Sep; 17(1):637. PubMed ID: 28882113 [TBL] [Abstract][Full Text] [Related]
3. The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice. Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA PLoS One; 2016; 11(7):e0159179. PubMed ID: 27428004 [TBL] [Abstract][Full Text] [Related]
4. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study. Huang WK; Chiou MJ; Yu KH; Lin YC; Yang TS; Chen JS; Kuo CF; See LC Aliment Pharmacol Ther; 2013 Aug; 38(4):432-9. PubMed ID: 23799975 [TBL] [Abstract][Full Text] [Related]
5. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin. Cea Soriano L; Lanas A; Soriano-Gabarró M; García Rodríguez LA Clin Gastroenterol Hepatol; 2019 Apr; 17(5):887-895.e6. PubMed ID: 29908361 [TBL] [Abstract][Full Text] [Related]
6. Incidence of intracranial bleeds in new users of low-dose aspirin: a cohort study using The Health Improvement Network. Cea Soriano L; Gaist D; Soriano-Gabarró M; García Rodríguez LA J Thromb Haemost; 2017 Jun; 15(6):1055-1064. PubMed ID: 28371181 [TBL] [Abstract][Full Text] [Related]
7. Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients. Tsoi KK; Chan FC; Hirai HW; Sung JJ J Gastroenterol Hepatol; 2018 Oct; 33(10):1728-1736. PubMed ID: 29665624 [TBL] [Abstract][Full Text] [Related]
8. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force. Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573 [TBL] [Abstract][Full Text] [Related]
9. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy. Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951 [TBL] [Abstract][Full Text] [Related]
10. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force. Chubak J; Whitlock EP; Williams SB; Kamineni A; Burda BU; Buist DS; Anderson ML Ann Intern Med; 2016 Jun; 164(12):814-25. PubMed ID: 27064482 [TBL] [Abstract][Full Text] [Related]
11. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care. Martín Merino E; Johansson S; Nagy P; García Rodríguez LA Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164 [TBL] [Abstract][Full Text] [Related]
12. The effect of low-dose aspirin on colorectal cancer prevention and gastrointestinal bleeding according to bodyweight and body mass index: Analysis of UK primary care data. Cea Soriano L; Vora P; Soriano-Gabarró M; García Rodríguez LA Int J Cardiol; 2019 Dec; 297():135-139. PubMed ID: 31515060 [TBL] [Abstract][Full Text] [Related]
13. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. García-Rodríguez LA; Huerta-Alvarez C Epidemiology; 2001 Jan; 12(1):88-93. PubMed ID: 11138826 [TBL] [Abstract][Full Text] [Related]
14. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Bibbins-Domingo K; Ann Intern Med; 2016 Jun; 164(12):836-45. PubMed ID: 27064677 [TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study. Shami JJP; Zhao J; Pathadka S; Wan EYF; Blais JE; Vora P; Soriano-Gabarró M; Cheung KS; Leung WK; Wong ICK; Chan EW BMJ Open; 2022 Feb; 12(2):e050510. PubMed ID: 35121597 [TBL] [Abstract][Full Text] [Related]
16. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381 [TBL] [Abstract][Full Text] [Related]
17. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care. García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412 [TBL] [Abstract][Full Text] [Related]
18. Risk of lower gastrointestinal bleeding and colorectal neoplasms following initiation of low-dose aspirin: a Danish population-based cohort study. Troelsen FS; Farkas DK; Erichsen R; Sørensen HT BMJ Open Gastroenterol; 2020 Jul; 7(1):. PubMed ID: 32719046 [TBL] [Abstract][Full Text] [Related]